Roussakis, E. 2023. Pharmaceutical Data Exclusivity in the Light of Access to Clinical Data: Is the EMA oversharing?. Stockholm Intellectual Property Law Review . 6, 2 (Dec. 2023), 25 – 34. DOI:https://doi.org/10.53292/62cdf208.5b66823e.